Sensei Biotherapeutics, Inc. · NASDAQ:SNSE

Caligan Partners LP reported a 9.40% stake in Sensei Biotherapeutics, Inc. (Schedule 13G)

Event Mar 31, 2026 · Filed May 15, 2026

Caligan Partners LP reported a 9.40% stake in Sensei Biotherapeutics, Inc., 126,002 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G).

Stake
9.40%
Shares
126,002
Intent
Passive
What changed
Crossed above 5%
Filed together
2 holders

The filing in full

HolderStakeShares
Caligan Partners LP9.40%126,002
David Johnson9.40%126,002

Source

View original at SEC

Related